Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Clinical Lymphoma, Myeloma & Leukemia|July 29, 2014
Identifying professional education gaps and barriers in multiple myeloma patient care: findings of the Managing Myeloma Continuing Educational Initiative Advisory CommitteeNoopur Raje, Beth Faiman, R Donald Harvey, et al.
Blood Cancer Journal|May 31, 2024
Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell TherapyDanai Dima, Al-Ola Abdallah, James A Davis, et al.
American Journal of Hematology|November 26, 2013
Mature results of MM-011: a phase I/II trial of liposomal doxorubicin, vincristine, dexamethasone, and lenalidomide combination therapy followed by lenalidomide maintenance for relapsed/refractory multiple myelomaAleksandr Lazaryan, Mohamad A Hussein, Frederic J Reu, et al.
Clinical Journal of Oncology Nursing|May 21, 2008
Management of side effects of novel therapies for multiple myeloma: consensus statements developed by the International Myeloma Foundation's Nurse Leadership BoardPage Bertolotti, Elizabeth Bilotti, Kathleen Colson, et al.
Blood Advances|January 4, 2018
A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myelomaAjai Chari, Hearn J Cho, Amishi Dhadwal, et al.
Leukemia & Lymphoma|August 20, 2020
A phase II study of pomalidomide, daily oral cyclophosphamide, and dexamethasone in relapsed/refractory multiple myelomaOliver Van Oekelen, Samir Parekh, Hearn J Cho, et al.
Pageof 7